Treatment with a VEGFR-2 antibody results in intra-tumor immune modulation and enhances anti-tumor efficacy of PD-L1 blockade in syngeneic murine tumor models

Prolonged activation of vascular endothelial growth factor receptor-2 (VEGFR-2) due to mis-regulation of the VEGF pathway induces aberrant blood vessel expansion, which supports growth and survival of solid tumors. Therapeutic interventions that inhibit the VEGFR-2 pathway have therefore become a ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yanxia, Amaladas, Nelusha, O’Mahony, Marguerita, Manro, Jason R., Inigo, Ivan, Li, Qi, Rasmussen, Erik R., Brahmachary, Manisha, Doman, Thompson N., Hall, Gerald, Kalos, Michael, Novosiadly, Ruslan, Puig, Oscar, Pytowski, Bronislaw, Schaer, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292077/
https://www.ncbi.nlm.nih.gov/pubmed/35849586
http://dx.doi.org/10.1371/journal.pone.0268244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292077/
https://www.ncbi.nlm.nih.gov/pubmed/35849586
http://dx.doi.org/10.1371/journal.pone.0268244

Ejemplares similares